Pacific Biosciences
PACB
NZ$2.42
Share price
-1.37%
Change (1 day)
-9.16%
Change (1 year)
Categories
Pacific Biosciences (PACB) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$1.29 Billion
According to Pacific Biosciences 's latest financial reports the company's total liabilities are NZ$1.29 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$1.33 B | -19.09% |
| 2023-12-31 | NZ$1.65 B | -12.9% |
| 2022-12-31 | NZ$1.89 B | 6.54% |
| 2021-12-31 | NZ$1.78 B | 1536.56% |
| 2020-12-31 | NZ$0.10 B | -21.28% |
| 2019-12-31 | NZ$0.13 B | 64.89% |
| 2018-12-31 | NZ$83.8 M | 2.65% |
| 2017-12-31 | NZ$81.64 M | 6.27% |
| 2016-12-31 | NZ$76.82 M | -8.66% |
| 2015-12-31 | NZ$84.11 M | -5.1% |
| 2014-12-31 | NZ$88.62 M | 8.69% |
| 2013-12-31 | NZ$81.53 M | 230.41% |
| 2012-12-31 | NZ$24.67 M | -28.28% |
| 2011-12-31 | NZ$34.4 M | 2.56% |
| 2010-12-31 | NZ$33.54 M | -91.24% |
| 2009-12-31 | NZ$0.38 B | 7.65% |
| 2008-12-31 | NZ$0.35 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | NZ$6.41 B | 395.87% | 🇺🇸 USA |
 NanoString Technologies NSTG | NZ$0.54 B | -57.71% | 🇺🇸 USA |
 General Electric GE | NZ$176.00 B | 13,506.56% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | NZ$83.34 B | 6,342.95% | 🇺🇸 USA |
 PerkinElmer
PKI | NZ$11.10 B | 758.65% | 🇺🇸 USA |